Information on this blog is being shared only for the purpose of creating legal awareness in public at large, especially in the field of Intellectual Property Right. As there may be possibility of error, omission or mistake in legal interpretation on the contents of this blog, it should not be treated as substitute for legal advise.
Monday, September 1, 2025
Zydus Wellness Products Ltd. Versus Karnal Foods Pack Cluster Limited
Vaidya Rishi India Health Private Limited & Anr. v. Suresh Dutt Parashar
Optix Healthcare & Ors. Vs. S. Baskaran
Muthukani Thiravidakani Trading as Anil Appalam and Chips & Anr. Vs K.Raja & Anr
Berkadia Proprietary Holding LLC Vs. The Registrar of Trade Marks
Haveli Restaurant and Resorts Ltd Vs Adison Resorts Limited
New Delhi Television Limited (NDTV) Vs Ashok Kumar & Ors
Shiv Industries Vs Lifetime Care Kitchen Pvt. Limited
Lotus Bakeries N V Vs Micks Products LLP
Shankar Engineering Works and Ors. Vs Sankar Iron Engineering Works Pvt. Ltd
Natural Medicine Institute of Zhejiang Vs The Deputy Controller of Patents
Modi-Mundipharma Pvt. Ltd. Vs. Lloyd Health Care Pvt. Ltd.
Utracon Corporation Pte Ltd Vs. Ucon Pt Structural System Private Limited
CMYK Printech Limited Vs. BAA Television Network Private Limited
Sunday, August 31, 2025
FMC Corporation & Ors. Vs Natco Pharma Limited
New Delhi Television Limited versus Ashok Kumar & Ors
Actavis UK Limited and others (Appellants) v Eli Lilly and Company
The case is Actavis UK Limited and others (Appellants) v Eli Lilly and Company (Respondent), decided by the United Kingdom Supreme Court on 12 July 2017, with the case number UKSC 48. The judgment was delivered by Lord Neuberger, President, with Lords Mance, Clarke, Sumption, and Hodge concurring.
The factual background involves pemetrexed, a chemical known for therapeutic effects on cancerous tumors but with significant toxic side effects when used alone. The patent in question, European Patent (UK) No 1 313 508, owned by Eli Lilly, disclosed that these side effects could be mitigated by administering pemetrexed disodium with vitamin B12, enabling a successful medicament marketed as Alimta since 2004. The patent claims focused on using pemetrexed disodium in medicaments combined with vitamin B12 for cancer treatment. Actavis developed products with pemetrexed diacid, pemetrexed ditromethamine, or pemetrexed dipotassium instead of pemetrexed disodium and contended that these did not infringe Eli Lilly’s patent. Eli Lilly argued that Actavis’s products infringed the patent directly or indirectly.
The main dispute was whether Actavis’s products infringed the patent claims limited to pemetrexed disodium. The lower court, Arnold J, initially found no infringement, with the Court of Appeal confirming no direct infringement but accepting indirect infringement. Eli Lilly appealed the rejection of direct infringement, and Actavis cross-appealed the finding of indirect infringement.
The Supreme Court held that Actavis’s products did directly infringe Eli Lilly’s patent in the UK and corresponding designations in France, Italy, and Spain, and dismissed Actavis’s cross-appeal on indirect infringement. The Court applied a nuanced approach to patent claim interpretation, emphasizing the Protocol on the Interpretation of Article 69 of the European Patent Convention, which calls for a balance between fair protection for patentees and legal certainty for third parties. The Court reformulated the established 'Improver' questions to determine infringement under the doctrine of equivalents, requiring that a variant achieves substantially the same result in substantially the same way, that it would be obvious to a skilled person that the variant works equivalently, and that the patentee did not intend a strict literal interpretation excluding such variants.
The Court found that although Actavis’s products did not literally fall within the claims limited to pemetrexed disodium, they were equivalent variants achieving the same therapeutic result through substantially the same means under the patent. The prosecution history limiting claims to pemetrexed disodium did not preclude the doctrine of equivalents extending protection to other pemetrexed salts or the free acid. The Court also confirmed that indirect infringement applies where the Actavis products, when dissolved in saline for administration, effectively produce pemetrexed disodium in solution.
This case clarified the application of the doctrine of equivalents in patent infringement, endorsing a purposive interpretation of patent claims that balances the literal wording with the inventive concept and the principle of equivalents. It provided guidance on how courts should approach equivalence, endorsing a more pragmatic approach whereby the skilled person assesses variants knowing the variant works, rather than speculating on outcomes without such knowledge. The decision is influential for patent law concerning pharmaceutical patents and equivalents.
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
Disclaimer: This information report is intended for informational purposes only and does not constitute legal advice.
Promoshirt SM SA Vs. Armasuisse
Introduction: The case of Promoshirt SM SA Vs. Armasuisse and Anr. is a pivotal decision by the High Court of Delhi that addresses the maintainability of Letters Patent Appeals (LPAs) under the Trade Marks Act, 1999, in light of Section 100-A of the Code of Civil Procedure, 1908 (CPC). This case arose from a challenge to a Single Judge’s judgment on appeals against the Deputy Registrar of Trade Marks’ order, raising a significant preliminary objection regarding the applicability of Section 100-A, which bars further appeals from a Single Judge’s appellate decisions. The Division Bench examined whether an LPA is permissible when a Single Judge exercises appellate jurisdiction under a special statute like the 1999 TM Act. The decision clarifies the scope of Section 100-A, the nature of the Registrar of Trade Marks as a non-civil court, and the preservation of Letters Patent remedies in trademark disputes, offering critical insights into appellate jurisdiction in intellectual property law.
Factual Background: Promoshirt SM SA, the appellant, sought registration of certain trademarks under the Trade Marks Act, 1999. Armasuisse, the respondent, opposed these applications, but the Deputy Registrar of Trade Marks, on July 25, 2022, rejected Armasuisse’s opposition and directed that Promoshirt’s trademark applications be processed for registration. Aggrieved, Armasuisse appealed to the High Court of Delhi under Section 91 of the 1999 TM Act, which allows appeals against the Registrar’s orders to be heard by a Single Judge. On January 4, 2023, the Single Judge delivered a judgment, prompting Promoshirt to file two Letters Patent Appeals (LPAs 136/2023 and 137/2023) before the Division Bench. Armasuisse raised a preliminary objection, arguing that Section 100-A of the CPC barred these LPAs, as the Single Judge was exercising appellate jurisdiction. The dispute centered on whether the Registrar’s orders constituted decrees or orders of a civil court under the CPC and whether the 1999 TM Act’s appellate framework permitted further appeals under the Letters Patent.
Procedural Background: The procedural journey began with the Deputy Registrar’s order on July 25, 2022, accepting Promoshirt’s trademark applications and rejecting Armasuisse’s opposition. Armasuisse invoked Section 91 of the 1999 TM Act to appeal this order to a Single Judge of the High Court of Delhi. The Single Judge’s judgment on January 4, 2023, led Promoshirt to file LPAs under Clause 10 of the Letters Patent, challenging the maintainability of the Single Judge’s decision. Armasuisse’s counsel, Mr. Pravin Anand, argued that Section 100-A of the CPC, which prohibits further appeals from a Single Judge’s appellate decisions, rendered the LPAs non-maintainable. The Division Bench was tasked with resolving this preliminary objection before addressing the substantive merits of the appeals, focusing on the interplay between the CPC, the 1999 TM Act, and the Letters Patent powers of the High Court.
Legal Issue: The primary legal issue was whether a Letters Patent Appeal is maintainable against a Single Judge’s judgment rendered under Section 91 of the Trade Marks Act, 1999, in light of Section 100-A of the Code of Civil Procedure, 1908, which bars further appeals from a Single Judge’s decisions in appeals from original or appellate decrees or orders? The court had to determine whether the Registrar of Trade Marks’ decisions constitute decrees or orders of a civil court under the CPC and whether the 1999 TM Act’s appellate provisions, lacking explicit reference to CPC rules, preserve the right to an LPA under the Letters Patent.
Discussion on Judgments: The court extensively referenced prior judgments to address the maintainability of the LPAs, with both parties citing precedents to support their positions. Armasuisse relied on Kamal Kumar Dutta & Anr. v. Ruby General Hospital Ltd. & Ors. ((2006) 7 SCC 613), where the Supreme Court held that Section 100-A overrides Letters Patent powers, barring further appeals from a Single Judge’s decision in an appeal from an original order of the Company Law Board (CLB). The court noted the CLB’s quasi-judicial nature and its trappings of a court, applying Section 100-A to preclude an LPA. Armasuisse argued this precedent conclusively settled the issue, as the Registrar’s orders were akin to those of the CLB.
The court also considered P.S. Sathappan v. Andhra Bank Ltd. ((2004) 11 SCC 672), a Constitution Bench decision cited by Armasuisse, which clarified that Section 100-A, as amended in 2002, specifically excludes LPAs when a Single Judge hears an appeal from an original or appellate decree or order. The court emphasized the legislature’s intent to limit appeals, reinforcing Armasuisse’s contention that Section 100-A applied universally.
Subal Paul v. Malina Paul ((2003) 10 SCC 361) was referenced, with Armasuisse highlighting the Supreme Court’s observation that statutory bars to appeals, like Section 100-A, must be expressly stated. This supported their argument that Section 100-A’s non-obstante clause overrides Letters Patent provisions. Similarly, Gandla Pannala Bhulaxmi v. Managing Director, A.P. SRTC (2003 SCC OnLine AP 525) and United India Insurance Co. Ltd. v. S. Surya Prakash Reddy & Ors. (2006 SCC OnLine AP 434), Full Bench decisions of the Andhra Pradesh High Court, were cited by Armasuisse. These cases held that Section 100-A bars LPAs in matters arising under special statutes like the Motor Vehicles Act, as the non-obstante clause overrides Letters Patent powers, even for tribunals with court-like functions.
Kesava Pillai Sreedharan Pillai v. State of Kerala (2003 SCC OnLine Ker 293), a Kerala High Court Full Bench decision, was invoked by Armasuisse to argue that Section 100-A’s amendments in 1999 and 2002 aimed to abolish intra-court appeals, except in writ petitions, applying to appeals under statutes like the Land Acquisition Act. Rouf Ahmad Zaroo v. Mst. Shafeeqa (2014 SCC OnLine J&K 137) was cited, where the Jammu and Kashmir High Court, relying on Kamal Kumar Dutta, held that Section 100-A barred an LPA from a Single Judge’s appellate order under the Guardians and Wards Act, reinforcing Armasuisse’s position.
Promoshirt countered with National Sewing Thread Co. Ltd. v. James Chadwick & Bros. (AIR 1953 SC 357), where the Supreme Court held that an appeal under Section 76 of the Trade Marks Act, 1940, to a Single Judge is subject to High Court rules, including Letters Patent appeals, unless the statute expressly bars further appeals. Promoshirt argued that the 1999 TM Act’s silence on further appeals preserved the LPA remedy. Mahli Devi (unreported, cited in the judgment), a Delhi High Court Full Bench decision, was referenced to assert that LPAs are maintainable under Section 54 of the Land Acquisition Act, as it lacks a bar on second appeals, supporting Promoshirt’s claim that the 1999 TM Act’s structure allows LPAs.
Resilient Innovations Pvt. Ltd. v. Phonepe Private Limited and Anr. (2023 SCC OnLine Del 2972) and V.R. Holdings v. Hero Investocorp Limited & Anr. (2023 SCC OnLine 4673), recent Delhi High Court decisions, were cited by Promoshirt. These cases held that LPAs are maintainable under the 1999 TM Act, as it lacks provisions excluding Letters Patent appeals, unlike its predecessors. The court in Resilient Innovations emphasized that the absence of CPC application in the 1999 TM Act preserves the LPA remedy under Clause 10 of the Letters Patent.
Avtar Narain Behal (not fully cited but discussed extensively) was a Delhi High Court Full Bench decision relied upon by Armasuisse, interpreting Section 100-A to bar LPAs under the Indian Succession Act, 1925, due to its adoption of CPC appeal provisions. Promoshirt distinguished this, arguing that the 1999 TM Act does not similarly incorporate CPC rules. Nahar Industrial Enterprises Ltd. v. Hong Kong & Shanghai Banking Corpn. ((2009) 8 SCC 646) was cited by Promoshirt to argue that tribunals like the Registrar of Trade Marks are not civil courts, as they lack the full attributes of a civil court, supporting the maintainability of LPAs.
Paramjeet Singh Patheja v. ICDS Ltd. ((2006) 13 SCC 322) was referenced by Promoshirt to clarify that non-civil court decisions, like arbitration awards, are not decrees under the CPC, reinforcing that the Registrar’s orders do not fall under Section 100-A. Additional cases included Sharda Devi v. State of Bihar ((2002) 3 SCC 705), supporting LPAs under the Land Acquisition Act; Aswini Kumar v. Arbinda Bose (AIR 1952 SC 369) and Madhav Rao Scindia v. Union of India (AIR 1971 SC 530), on the scope of non-obstante clauses; and I.T.C. Ltd. v. State of Karnataka (1985 Supp SCC 476) and Kulwant Kaur v. Gurdial Singh Mann ((2001) 4 SCC 262), on the supremacy of central legislation, all contextualizing the interplay between CPC and special statutes.
Reasoning and Analysis of the Judge: The Division Bench began by examining Section 100-A’s language, which bars further appeals from a Single Judge’s decisions in appeals from original or appellate decrees or orders, noting its non-obstante clause overriding Letters Patent provisions. However, the court emphasized that Section 100-A’s applicability hinges on the definitions of “decree” and “order” under Sections 2(2) and 2(14) of the CPC, which require adjudication by a civil court. The Registrar of Trade Marks, as a statutory authority, does not qualify as a civil court, as it lacks the power to conduct trials under the CPC or Evidence Act, failing the “trappings of a court” test articulated in Nahar Industrial Enterprises and Paramjeet Singh Patheja.
The court distinguished precedents like Kamal Kumar Dutta, which applied Section 100-A to the CLB due to its quasi-judicial status and statutory deeming provisions under the Companies Act, 1956. Unlike the CLB or Motor Accident Claims Tribunals, which have limited civil court status under their statutes, the 1999 TM Act contains no such provision, and the Registrar’s role is administrative, not judicial. The court also contrasted the 1999 TM Act with its predecessors, noting that Sections 76(3) of the 1940 TM Act and 109(8) of the 1958 TM Act applied CPC rules to appeals, a feature absent in the 1999 TM Act, indicating legislative intent to preserve Letters Patent remedies.
Analyzing Avtar Narain Behal, the court clarified that its holding applied to the Indian Succession Act, 1925, because Section 299 explicitly subjects appeals to CPC provisions, attracting Section 100-A’s bar. In contrast, Section 91 of the 1999 TM Act is silent on CPC application, aligning with National Sewing Thread and Mahli Devi, which upheld LPAs absent statutory bars. The court reconciled these precedents by holding that Section 100-A applies only when a special statute adopts CPC appeal rules or when the original decision emanates from a civil court.
The court further addressed the legislative intent behind Section 100-A, noting its aim to limit appeals in civil court matters, as per the CPC’s preamble, which governs “courts of civil judicature.” Extending Section 100-A to all special statutes would overstep its scope, especially for non-civil court authorities like the Registrar. The decisions in Resilient Innovations and V.R. Holdings were upheld as correctly interpreting the 1999 TM Act’s framework, reinforcing that LPAs remain viable absent express exclusion.
Final Decision: The Division Bench overruled Armasuisse’s preliminary objection, holding that the LPAs were maintainable. The court directed that the appeals (LPA 136/2023 and LPA 137/2023) be listed for consideration on their merits on September 19, 2023, affirming that Section 100-A does not bar LPAs against a Single Judge’s judgment under Section 91 of the 1999 TM Act.
Law Settled in This Case: The case established several key principles in trademark and appellate law. First, Section 100-A of the CPC bars further appeals only from decrees or orders of a civil court, as defined under Sections 2(2) and 2(14), and does not apply to decisions of non-civil court authorities like the Registrar of Trade Marks. Second, the Registrar of Trademark does not qualify as a civil court, lacking the attributes of conducting trials under the CPC or Evidence Act, as per the “trappings of a court” test. Third, the 1999 TM Act’s silence on applying CPC rules to appeals, unlike its predecessors, preserves the right to LPAs under the Letters Patent unless expressly barred. Fourth, Section 100-A applies to special statutes only when they explicitly subject appeals to CPC provisions, as in the Indian Succession Act, 1925, but not in the 1999 TM Act. Finally, the court affirmed that Letters Patent remedies remain intact for trademark appeals under Section 91, ensuring an additional layer of judicial scrutiny absent statutory restrictions.
Disclaimer: The information shared here is intended to serve the public interest by offering insights and perspectives. However, readers are advised to exercise their own discretion when interpreting and applying this information. The content herein is subjective and may contain errors in perception, interpretation, and presentation.
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
Saturday, August 30, 2025
Frimline Private Limited & Anr Vs K-Smatco Lifesciences Private Limited & Ors
Bhagirati Enterprises and Anr Vs Kirti Enterprises
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
Disclaimer: This information report is intended for informational purposes only and does not constitute legal advice.
Goodview Fashion Private Limited Vs The Registrar of Trade Marks
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
Blog Archive
- December 2025 (100)
- November 2025 (62)
- October 2025 (44)
- September 2025 (75)
- August 2025 (103)
- July 2025 (95)
- June 2025 (93)
- May 2025 (118)
- April 2025 (91)
- March 2025 (148)
- February 2025 (116)
- January 2025 (58)
- October 2024 (8)
- September 2024 (34)
- August 2024 (68)
- July 2024 (39)
- June 2024 (57)
- May 2024 (49)
- April 2024 (6)
- March 2024 (44)
- February 2024 (39)
- January 2024 (21)
- December 2023 (29)
- November 2023 (23)
- October 2023 (27)
- September 2023 (33)
- August 2023 (29)
- July 2023 (29)
- June 2023 (2)
- May 2023 (1)
- April 2023 (5)
- March 2023 (6)
- February 2023 (1)
- November 2022 (17)
- October 2022 (11)
- September 2022 (30)
- August 2022 (46)
- July 2022 (36)
- June 2022 (26)
- October 2020 (1)
- September 2020 (1)
- April 2020 (1)
- March 2020 (1)
- February 2020 (2)
- December 2019 (1)
- September 2019 (3)
- August 2019 (2)
- July 2019 (1)
- June 2019 (2)
- April 2019 (3)
- March 2019 (2)
- February 2019 (2)
- January 2019 (2)
- December 2018 (3)
- November 2018 (1)
- October 2018 (2)
- September 2018 (2)
- August 2018 (8)
- July 2018 (2)
- June 2018 (1)
- May 2018 (41)
- April 2018 (7)
- March 2018 (3)
- February 2018 (4)
- January 2018 (2)
- December 2017 (6)
- November 2017 (4)
- September 2017 (5)
- August 2017 (6)
- July 2017 (1)
- June 2017 (1)
- May 2017 (10)
- April 2017 (16)
- November 2016 (3)
- October 2016 (24)
- March 2015 (2)
- January 2014 (1)
- December 2013 (4)
- October 2013 (2)
- September 2013 (7)
- August 2013 (27)
- May 2013 (7)
- September 2012 (31)
- December 2009 (3)
- September 2009 (1)
- March 2009 (3)
- January 2009 (2)
- December 2008 (1)
Featured Post
WHETHER THE REGISTRAR OF TRADEMARK IS REQUIRED TO BE SUMMONED IN A CIVIL SUIT TRIAL PROCEEDING
WHETHER THE REGISTRAR OF TRADEMARK IS REQUIRED TO BE SUMMONED IN A CIVIL SUIT TRIAL PROCEEDING IN ORDER TO PROVE THE TRADEMARK REGISTRA...
-
A Party is not allowed to argue a case, what is not pleaded. Introduction: This case revolves around a fundamental principle of civil proce...
-
Introduction In the dynamic realm of pharmaceutical innovation, where intellectual property rights safeguard groundbreaking discoveries, th...
My Blog List
-
नदी के पार - दो युवा सन्यासी प्रातःकाल के धुंधलके में अपनी यात्रा पर निकले थे। सामने एक चौड़ी, वेगवती नदी थी—बरसात के कारण जल उफान पर था। दोनों ने अपने वस्त्र समेटे ...14 hours ago
-
IPL:Spice In, Nationality Out - I was sitting in my office. It was a hot afternoon. The fan was running slowly and making strange sounds like an old typewriter. Files were lying on my d...7 months ago
-
-
My other Blogging Links
- Ajay Amitabh Suman's Poem and Stories
- Facebook-My Judgments
- Katha Kavita
- Lawyers Club India Articles
- My Indian Kanoon Judgments
- Linkedin Articles
- Speaking Tree
- You Tube-Legal Discussion
- बेनाम कोहड़ा बाजारी -Facebook
- बेनाम कोहड़ा बाजारी -वर्ड प्रेस
- बेनाम कोहड़ा बाजारी-दैनिक जागरण
- बेनाम कोहड़ा बाजारी-नवभारत टाइम्स
- बेनाम कोहड़ा बाजारी-ब्लॉग स्पॉट
- बेनाम कोहड़ा बाजारी-स्पीकिंग ट्री